200 related articles for article (PubMed ID: 11376868)
41. Dephosphorylation of Vav is associated with the induction of mouse erythroleukemia cell differentiation: effects of orthovanadate and levamisole.
Scher BM; Wei XJ; Waxman S; Scher W
Int J Oncol; 1998 Jun; 12(6):1307-13. PubMed ID: 9592191
[TBL] [Abstract][Full Text] [Related]
42. PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells.
Fernández-Nestosa MJ; Hernández P; Schvartzman JB; Krimer DB
Leuk Res; 2008 Jan; 32(1):121-30. PubMed ID: 17586044
[TBL] [Abstract][Full Text] [Related]
43. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction.
Green AR; Rockman S; DeLuca E; Begley CG
Exp Hematol; 1993 Apr; 21(4):525-31. PubMed ID: 8462662
[TBL] [Abstract][Full Text] [Related]
44. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells.
Kiyokawa H; Ngo L; Kurosaki T; Rifkind RA; Marks PA
Cell Growth Differ; 1992 Jun; 3(6):377-83. PubMed ID: 1419901
[TBL] [Abstract][Full Text] [Related]
45. Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cells.
Michaeli J; Lebedev YB; Richon VM; Chen ZX; Marks PA; Rifkind RA
Mol Cell Biol; 1990 Jul; 10(7):3535-40. PubMed ID: 1972544
[TBL] [Abstract][Full Text] [Related]
46. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
[TBL] [Abstract][Full Text] [Related]
47. Impaired erythroid-specific gene expression in cAMP-dependent protein kinase-deficient murine erythroleukemia cells.
Pilz RB
J Biol Chem; 1993 Sep; 268(27):20252-8. PubMed ID: 8376386
[TBL] [Abstract][Full Text] [Related]
48. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of nuclear distribution protein (hNUDC) causes pro-apoptosis and differentiation in Dami megakaryocytes.
Xiao Y; Zheng Y; Tan P; Xu P; Zhang Q
Cell Prolif; 2013 Oct; 46(5):576-85. PubMed ID: 24010816
[TBL] [Abstract][Full Text] [Related]
50. Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells.
Petrak J; Myslivcova D; Man P; Cmejlova J; Cmejla R; Vyoral D
Exp Hematol; 2007 Feb; 35(2):193-202. PubMed ID: 17258068
[TBL] [Abstract][Full Text] [Related]
51. Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis.
Soucek K; Pacherník J; Kubala L; Vondrácek J; Hofmanová J; Kozubík A
Leuk Res; 2006 May; 30(5):607-23. PubMed ID: 16242776
[TBL] [Abstract][Full Text] [Related]
52. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells.
Yamato K; Koseki T; Ohguchi M; Kizaki M; Ikeda Y; Nishihara T
Mol Endocrinol; 1997 Jul; 11(8):1044-52. PubMed ID: 9212052
[TBL] [Abstract][Full Text] [Related]
53. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
Kalina U; Koschmieder S; Hofmann WK; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
Exp Hematol; 2001 May; 29(5):602-8. PubMed ID: 11376873
[TBL] [Abstract][Full Text] [Related]
54. Notch-1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways.
Jang MS; Miao H; Carlesso N; Shelly L; Zlobin A; Darack N; Qin JZ; Nickoloff BJ; Miele L
J Cell Physiol; 2004 Jun; 199(3):418-33. PubMed ID: 15095289
[TBL] [Abstract][Full Text] [Related]
55. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
56. Alterations in electrophoretic mobility, diaphorase activity, and terminal differentiation induced in murine erythroleukemia lines by differentiating agents.
Gascoyne PR; Becker FF
J Cell Physiol; 1990 Feb; 142(2):309-15. PubMed ID: 2303526
[TBL] [Abstract][Full Text] [Related]
57. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
[TBL] [Abstract][Full Text] [Related]
58. Phenylacetate inhibits growth and modulates cell cycle gene expression in renal cancer cell lines.
Franco OE; Onishi T; Umeda Y; Soga N; Wakita T; Arima K; Yanagawa M; Sugimura Y
Anticancer Res; 2003; 23(2B):1637-42. PubMed ID: 12820434
[TBL] [Abstract][Full Text] [Related]
59. Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.
Ezhevsky SA; Toyoshima H; Hunter T; Scott DW
Mol Biol Cell; 1996 Apr; 7(4):553-64. PubMed ID: 8730099
[TBL] [Abstract][Full Text] [Related]
60. Differential expression of Ran GTPase during HMBA-induced differentiation in murine erythroleukemia cells.
Vanegas N; García-Sacristán A; López-Fernández LA; Párraga M; del Mazo J; Hernández P; Schvartzman JB; Krimer DB
Leuk Res; 2003 Jul; 27(7):607-15. PubMed ID: 12681360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
